XML 47 R37.htm IDEA: XBRL DOCUMENT
v3.21.1

Financial Instruments (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
Investments, All Other Investments [Abstract] |
Carrying Amount and Estimated Fair Values of Financial Instruments | The carrying values and the estimated fair values of financial instruments at March 31, 2021 and December 31, 2020 consisted of the following:
| March 31, 2021 |  | December 31, 2020
(DOLLARS IN MILLIONS) | Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
LEVEL 1 |  |  |  |  |  |  |
Cash and cash equivalents(1) | $ | 872 |  |  | $ | 872 |  |  | $ | 650 |  |  | $ | 650 |
2025 Notes(6) | 1,001 |  |  | 982 |  |  | — |  |  | — |
2027 Notes(6) | 1,220 |  |  | 1,172 |  |  | — |  |  | — |
2030 Notes(6) | 1,511 |  |  | 1,454 |  |  | — |  |  | — |
2040 Notes(6) | 775 |  |  | 736 |  |  | — |  |  | — |
2050 Notes(6) | 1,574 |  |  | 1,470 |  |  | — |  |  | — |
LEVEL 2 |  |  |  |  |  |  |
Credit facilities and bank overdrafts(2) | 11 |  |  | 11 |  |  | 2 |  |  | 2 |
Derivatives |  |  |  |  |  |  |
Derivative assets(3) | 3 |  |  | 3 |  |  | 1 |  |  | 1 |
Derivative liabilities(3) | 18 |  |  | 18 |  |  | 29 |  |  | 29 |
Long-term debt:(4) |  |  |  |  |  |  |
2021 Euro Notes | 353 |  |  | 353 |  |  | 368 |  |  | 370 |
2022 Notes | 300 |  |  | 300 |  |  | — |  |  | — |
2023 Notes | 299 |  |  | 314 |  |  | 299 |  |  | 316 |
2024 Euro Notes | 587 |  |  | 615 |  |  | 614 |  |  | 648 |
2026 Euro Notes | 936 |  |  | 1,008 |  |  | 978 |  |  | 1,061 |
2028 Notes | 397 |  |  | 453 |  |  | 397 |  |  | 472 |
2047 Notes | 494 |  |  | 561 |  |  | 494 |  |  | 608 |
2048 Notes | 786 |  |  | 984 |  |  | 786 |  |  | 1,059 |
2018 Term Loan Facility(2) | 240 |  |  | 240 |  |  | 240 |  |  | 240 |
2022 Term Loan Facility(2) | 200 |  |  | 200 |  |  | 199 |  |  | 200 |
2024 Term Loan Facility(7) | 625 |  |  | 625 |  |  | — |  |  | — |
2026 Term Loan Facility(7) | 625 |  |  | 625 |  |  | — |  |  | — |
Amortizing Notes(5) | 24 |  |  | 25 |  |  | 36 |  |  | 37 |
_______________________ (1)The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments. (2)The carrying amount approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments. (3)The carrying amount approximates fair value as the instruments are marked-to-market and held at fair value on the Consolidated Balance Sheet. (4)The fair value of the Company's long-term debt was calculated using discounted cash flows applying current interest rates and current credit spreads based on its own credit risk. (5)The fair value of the Amortizing Notes of the TEUs is based on the most recently quoted price for the outstanding securities, adjusted for any known significant deviation in value. The estimated fair value of these long-term obligations is not necessarily indicative of the amount that would be realized in a current market exchange. (6)The fair value of the Notes is based on market quoted price as there is an active market for the Notes and observable market data and inputs. (7)The carrying amount approximates fair value as the Term Loans were assumed at fair value and the interest rate is reset frequently based on current market rates.
Derivative Instruments Notional Amount Outstanding | The following table shows the notional amount of the Company’s derivative instruments outstanding as of March 31, 2021 and December 31, 2020:
(DOLLARS IN MILLIONS) | March 31, 2021 |  | December 31, 2020
Foreign currency contracts | $ | 121 |  |  | $ | 221 |
Commodity contracts | 5 |  |  | — |
Cross currency swaps | 300 |  |  | 300 |
Derivative Instruments Measured at Fair Value | The following tables show the Company’s derivative instruments measured at fair value (Level 2 of the fair value hierarchy), as reflected in the Consolidated Balance Sheet as of March 31, 2021 and December 31, 2020:
| March 31, 2021
(DOLLARS IN MILLIONS) | Fair Value of Derivatives Designated as Hedging Instruments |  | Fair Value of Derivatives Not Designated as Hedging Instruments |  | Total Fair Value
Derivative assets(1) |  |  |  |  |
Foreign currency contracts | $ | 2 |  |  | $ | 1 |  |  | $ | 3 |
Derivative liabilities(2) |  |  |  |  |
Foreign currency contract | $ | — |  |  | $ | 7 |  |  | $ | 7 |
Cross currency swaps | 11 |  |  | — |  |  | 11 |
Total derivative liabilities | $ | 11 |  |  | $ | 7 |  |  | $ | 18 |
| December 31, 2020
(DOLLARS IN MILLIONS) | Fair Value of Derivatives Designated as Hedging Instruments |  | Fair Value of Derivatives Not Designated as Hedging Instruments |  | Total Fair Value
Derivative assets(1) |  |  |  |  |
Foreign currency contracts | $ | — |  |  | $ | 1 |  |  | $ | 1 |
Derivative liabilities(2) |  |  |  |  |
Foreign currency contracts | $ | 6 |  |  | $ | — |  |  | $ | 6 |
Cross currency swaps | 23 |  |  | — |  |  | 23 |
Total derivative liabilities | $ | 29 |  |  | $ | — |  |  | $ | 29 |
_______________________ (1)Derivative assets are recorded to Prepaid expenses and other current assets in the Consolidated Balance Sheet. (2)Derivative liabilities are recorded as Other current liabilities in the Consolidated Balance Sheet
Derivative Instruments Which Were Not Designated as Hedging Instruments | The following table shows the effect of the Company’s derivative instruments which were not designated as hedging instruments in the Consolidated Statement of (Loss) Income and Comprehensive Loss for the three months ended March 31, 2021 and 2020 (in millions):
| Amount of Gain (Loss) |  | Location of Gain (Loss) Recognized in Income on Derivative
(DOLLARS IN MILLIONS) | Three Months Ended March 31, |
2021 |  | 2020 |
Foreign currency contracts(1) | $ | (3) |  |  | $ | (8) |  |  | Other (income) expense, net
_______________________ (1)The foreign currency contract net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods.
Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments | The following table shows the effect of the Company’s derivative and non-derivative instruments designated as cash flow and net investment hedging instruments, net of tax, in the Consolidated Statement of (Loss) Income and Comprehensive Loss for the three months ended March 31, 2021 and 2020 (in millions):
| Amount of Gain (Loss) Recognized in OCI on Derivative |  | Location of Gain (Loss) Reclassified from AOCI into Income |  | Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
| Three Months Ended March 31, |  |  | Three Months Ended March 31,
(DOLLARS IN MILLIONS) | 2021 |  | 2020 |  |  | 2021 |  | 2020
Derivatives in Cash Flow Hedging Relationships: |  |  |  |  |  |  |  |  |
Foreign currency contracts | $ | 4 |  |  | $ | 1 |  |  | Cost of goods sold |  | $ | (2) |  |  | $ | 2 |
Derivatives in Net Investment Hedging Relationships: |  |  |  |  |  |  |  |  |
Cross currency swaps | 9 |  |  | 21 |  |  | N/A |  | — |  |  | — |
Non-Derivatives in Net Investment Hedging Relationships: |  |  |  |  |  |  |  |  |
2024 Euro Notes | 20 |  |  | 10 |  |  | N/A |  | — |  |  | — |
2021 Euro Notes & 2026 Euro Notes | 45 |  |  | 21 |  |  | N/A |  | — |  |  | — |
Total | $ | 78 |  |  | $ | 53 |  |  |  |  | $ | (2) |  |  | $ | 2 |

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the notional amounts of outstanding derivative positions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959 + Details
Name: | us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4CC -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959 + Details
Name: | us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration